RaQualia Pharma rebounds for first time in four sessions after receiving patent approval in South Korea for TRPV4 antagonist
RaQualia Pharma Inc. <4579> rebounded for the first time in four sessions after announcing after market close on the 2nd that it received patent approval in South Korea for a substance patent covering its pyrimidin-4(3H)-one derivative, a TRPV4 antagonist. The announcement drew buying interest.
The company's TRPV4 antagonist has demonstrated high efficacy in multiple animal models of pain, inflammation, and eye diseases. The compound previously received patent approvals in China, Japan, Europe, and the U.S.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
-
Tokyo stocks open higher, supported by Wall Street gains
Thu Sep 3, 2026 9:04 am JST Market -
Nitori Holdings surges in sharp rebound as August same-store sales rise for second straight month
Thu Sep 3, 2026 9:19 am JST Catalyst -
U.S. stocks rebound on the 2nd, Dow Jones rises 295 dollars on technical buying
Thu Sep 3, 2026 8:13 am JST Market -
ABC-MART rebounds after 8 sessions as August same-store sales rise for second straight month
Thu Sep 3, 2026 9:12 am JST Catalyst -
U.S. forex market summary: Dollar temporarily softens to 158.20 yen range on expectations of accelerated BOJ rate hikes
Thu Sep 3, 2026 7:55 am JST Currency -
FAST RETAILING shares weak as domestic Uniqlo same-store sales fall below year-ago levels for first time in two months in August
Thu Sep 3, 2026 9:04 am JST Catalyst -
Axelspace Holdings surges sharply after signing satellite imagery sales partnership with Airbus Defence and Space
Thu Sep 3, 2026 9:19 am JST Catalyst -
NEC continues to battle near 25-day moving average after announcing strategic defense partnership with Mitsubishi Heavy Industries
Thu Sep 3, 2026 9:15 am JST Catalyst -
Singapore Nikkei 225 futures open at 64,535 yen (+110 yen) on the 3rd
Thu Sep 3, 2026 8:37 am JST Market -
Tokyo stocks seen rebounding on Sept. 3, but upside limited amid persistent crude oil concerns
Thu Sep 3, 2026 8:01 am JST Market